Ukraine Ministry of Health to Formally Register Favipiravir as a COVID-19 Treatment
TrialSite reported that in Russia, the Ministry of Health approved the generic form of Favipiravir, the Japanese generic of the […]
TrialSite reported that in Russia, the Ministry of Health approved the generic form of Favipiravir, the Japanese generic of the […]
NYU Langone has just embarked on a small and targeted yet critically important pilot study. The study team now investigates new […]
On Wednesday, US President Donald Trump suggested that the recent initiative by the FDA to tighten-up COVID-19 vaccine guidelines was politically-motivated. More […]
The nation of Indonesia, the fourth most populous worldwide, has inked a deal with AstraZeneca to buy 100 million COVID-19 […]
Researchers from Tsinghua University and Wuhan-based Union Hospital (associated with Huazhong University of Science and Technology) have developed an artificial […]
As the COVID-19 pandemic reached the United States, the American Lung Association announced the COVID-19 Action Initiative, designed to accelerate […]
Officials from the US Department of Health and Human Services (HHS) visited with leaders from Meridian Clinical Research in Savannah, GA. Following […]
Washington University School of Medicine (WUSM) in St. Louis now leads a Phase 3 clinical trial, funded by the National […]
TrialSite shares the American Society of Health-System Pharmacists (ASHP) maintains an “Assessment of Evidence for COVID-19-Related Treatments.” Updated most recently […]
A vaccine targeting COVID-19 out of China called BBIBP-CorV, an inactivated SARS-CoV-2 vaccine, is safe and well-tolerated at all tested […]